Alfasigma Acquires Near-To-Market PBC Drug From GSK

 
• By Joseph Haas
  
Liver
Alfasigma hopes to get back on market in PBC by licensing linerixibat
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business